As a subsidiary of Daicel Corporation, Chiral Technologies, Inc. d/b/a Daicel Chiral Technologies, is a global market leader in chromatography products for the life sciences market, offering an extensive portfolio of both achiral and chiral stationary phases. Scientists in the pharmaceutical, agricultural and food industries, universities read moreand government agencies rely on our expertise to analyze and purify molecules in research and development departments, QC laboratories and manufacturing. [website]

Established in 2001, Drug Discovery Alliances, Inc., is a US-based pharmaceutical consultancy specializing in small molecule R&D alliances. Our platform, backed by scientists and vetted suppliers, helps clients navigate challenges from discovery to commercialization. We focus on cost-effective API syntheses, supplier backup, and technology solutions. Areas of focus read moreincluding developing robust syntheses to lower cost of API's, backup supplier mitigation, and incorporating technology based solutions to overcome manufacturing challenges are just some of examples of how we have helped our clients. Our alliance partners provide the following services spanning the R&D continuum including: medicinal chemistry, in vivo studies, in vitro studies, process research, cGMP API manufacturing, RSM manufacturing, commercial manufacturing, formulation, crystallization R&D, drug product manufacturing, sourcing, generic API sourcing, GMP audits, CMC consulting, regulatory consulting, and assisting companies with licensing and fund raising activities. [website]

The Dipharma Group is a global CDMO and one of the leading family-owned manufacturers of Active Pharmaceutical Ingredients and Intermediates, having a portfolio of more than 40 products, with Drug Master Files lodged worldwide. Dipharma serves top ranking pharmaceutical companies in Europe, U.S.A. and Japan. Supported by read morea fully equipped R&D Centers, its core technologies are Nitration, Nitroesterification, Azide Chemistry, High Pressure Hydrogenation, Chiral Synthesis, Organometallic Chemistry and Enzymatic Processes. [website]

DOTTIKON EXCLUSIVE SYNTHESIS is specialized on hazardous chemistry, with a focus on strongly exothermic reactions as well as unstable, highly reactive, or high-potent compounds or mixtures. DOTTIKON ES manufactures high-quality intermediates and exclusive APIs, from the kilogram to the multi-ton range, for the world's leading pharmaceutical and chemical read moreindustries. Hazardous reactions often allow to shorten production and synthesic procedures, reduce waste, improve yields, selectivity, and purity, and therefore reduce overall costs. Among the core strengths of DOTTIKON ES are: hazardous reactions, such as reductions with complex hydrides, alkylations, azide chemistry, nitrations and oxidations. As well as heterogeneous and homogeneous catalytic hydrogenations, continuous reaction technologies and low temperature reactions. [website]